BIOMAT Database Logo BIOMAT Database Logo

Malignant disease in Bloom's syndrome children treated with growth hormone. 1991

P R Brock, and F de Zegher, and M Casteels-Van Daele, and M Vanderschueren-Lodeweyckx

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D001816 Bloom Syndrome An autosomal recessive disorder characterized by telangiectatic ERYTHEMA of the face, photosensitivity, DWARFISM and other abnormalities, and a predisposition toward developing cancer. The Bloom syndrome gene (BLM) encodes a RecQ-like DNA helicase. Bloom-Torre-Machacek Syndrome,Bloom's Syndrome,Congenital Telangiectatic Erythema,Bloom Torre Machacek Syndrome,Bloom's Syndromes,Congenital Telangiectatic Erythemas,Erythema, Congenital Telangiectatic,Telangiectatic Erythema, Congenital
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D013006 Growth Hormone A polypeptide that is secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. Species-specific growth hormones have been synthesized. Growth Hormone, Recombinant,Pituitary Growth Hormone,Recombinant Growth Hormone,Somatotropin,Somatotropin, Recombinant,Growth Hormone, Pituitary,Growth Hormones Pituitary, Recombinant,Pituitary Growth Hormones, Recombinant,Recombinant Growth Hormones,Recombinant Pituitary Growth Hormones,Recombinant Somatotropins,Somatotropins, Recombinant,Growth Hormones, Recombinant,Recombinant Somatotropin
D016393 Lymphoma, B-Cell A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes. B-Cell Lymphoma,B Cell Lymphoma,B-Cell Lymphomas,Lymphoma, B Cell,Lymphomas, B-Cell

Related Publications

P R Brock, and F de Zegher, and M Casteels-Van Daele, and M Vanderschueren-Lodeweyckx
Malignant lymphoma in a Bloom's syndrome patient treated with insulin.
July 1993, Clinical genetics,
P R Brock, and F de Zegher, and M Casteels-Van Daele, and M Vanderschueren-Lodeweyckx
Bloom's syndrome with growth hormone deficiency: a rare association.
October 2020, BMJ case reports,
P R Brock, and F de Zegher, and M Casteels-Van Daele, and M Vanderschueren-Lodeweyckx
[Bloom's syndrome. A case with deficit of growth hormone (author's transl)].
February 1979, Anales espanoles de pediatria,
P R Brock, and F de Zegher, and M Casteels-Van Daele, and M Vanderschueren-Lodeweyckx
Creutzfeldt-Jakob disease in children treated with growth hormone.
April 1991, Lancet (London, England),
P R Brock, and F de Zegher, and M Casteels-Van Daele, and M Vanderschueren-Lodeweyckx
Body weight in children with Turner syndrome treated with growth hormone.
October 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity,
P R Brock, and F de Zegher, and M Casteels-Van Daele, and M Vanderschueren-Lodeweyckx
[Creutzfeldt-Jakob disease in 4 children treated with growth hormone].
January 1992, Revue neurologique,
P R Brock, and F de Zegher, and M Casteels-Van Daele, and M Vanderschueren-Lodeweyckx
Sudden death in growth hormone-treated children with Prader-Willi syndrome.
January 2004, The Journal of pediatrics,
P R Brock, and F de Zegher, and M Casteels-Van Daele, and M Vanderschueren-Lodeweyckx
Growth impairment and growth hormone therapy in children treated for malignant brain tumours.
October 1997, European journal of pediatrics,
P R Brock, and F de Zegher, and M Casteels-Van Daele, and M Vanderschueren-Lodeweyckx
Leukaemia in children with growth hormone deficiency not treated with growth hormone.
May 1995, European journal of pediatrics,
P R Brock, and F de Zegher, and M Casteels-Van Daele, and M Vanderschueren-Lodeweyckx
Leukemia in children treated with growth hormone.
November 1998, Trends in endocrinology and metabolism: TEM,
Copied contents to your clipboard!